| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
November 12, 2008 |
|
|
| |
|
|
| |
|
|
|
TBA, Boston,MA
3/5/2009 to 3/6/2009
The 6th Anti-Infectives Partnering & Deal-Making Summit is a specialty conference for leading professionals in business development and infectious disease research. The Summit covers the industry's partnerships and alliances while providing a forum for new collaborations and information exchange. It also provides attendees with key insights on future deals as well as reports on new funding opportunities. Don't miss this unique forum!
|
|
|
|
|
|
|
|
|
Organized by:
|
|
GTCbio |
|
|
Invited Speakers:
|
|
Gail Cassell
Vice President, Scientific Affairs
Distinguished Lilly Research Scholar for Infectious Diseases
Eli Lilly & Co.
Neil Berkley
Director of Business Development
MPEX Pharmaceuticals
James Chafouleas, Ph.D.
Director, Global Licensing – Virology
Boehringer-Ingelheim
Michael T. Clark
Senior Director, Strategic Alliances
Pfizer
Mark Coflin
Executive Director, Global Alliance Management
Novartis Pharmaceuticals Corporation
Danielle Drayton
Therapeutic Area Director, Infectious Diseases & DecisionBase
Decision Resources
Mike Dudley
Senior Vice President, Research and Development
MPEX Pharmaceuticals
Roger Echols
Consultant
ID3C
John Hollway
SVP, Corporate Development
Achaogen
Barry Mason
Director, Business Development
NovaBiotics Ltd.
Sameeh Salama
Senior Director, Business Development
NAEJA Pharmaceutical, Inc.
Glenn Tillotson
Viropharma
David Wurtman
Vice President, Corporate Development
Nexbio
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2009-02-05
|
|
|
|
|
|
|
|
Registration:
|
|
https://gtcbio.com/userpart/user_registration.aspx?Str=144
|
|
|
E-mail:
|
|
nina.tran@gtcbio.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|